Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Patients With Myasthenia Gravis in China
Sponsor: AstraZeneca
Summary
This study is a multi-center, prospective cohort study designed to characterize current clinical practice, clinical and patient-reported outcomes (PROs), disease prognosis, treatment patterns and healthcare resource utilization for Chinese patients with myasthenia gravis (MG). This study will enroll patients with MG as diagnosed by physician. Approximately 1,200 MG patients are intended to be recruited from approximately 40 sites across majority of regions in China. The clinical and PROs included MGFA class, MGFA PIS, MG-ADL (Activities of Daily Living), QMG (Quantitative MG score), MG QOL-15R, EQ-5D etc. All MG patients enrolled will be followed up every 6 months until end of 2027.
Official title: A Multicenter, Prospective Cohort Study in Patients With Myasthenia Gravis in China
Key Details
Gender
All
Age Range
0 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1199
Start Date
2024-09-26
Completion Date
2027-12-30
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Locations (20)
Research Site
Beijing, China
Research Site
Chengdu, China
Research Site
Fuzhou, China
Research Site
Guangzhou, China
Research Site
Guiyang, China
Research Site
Harbin, China
Research Site
Hebei, China
Research Site
Henan, China
Research Site
Inner Mongolia, China
Research Site
Jiangsu, China
Research Site
Lanzhou, China
Research Site
Nanning, China
Research Site
Qingdao, China
Research Site
Taiyuan, China
Research Site
Tianjin, China
Research Site
Ürümqi, China
Research Site
Wenzhou, China
Research Site
Wuhan, China
Research Site
Xi'an, China
Research Site
Yinchuan, China